Mint Tower Capital Management’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Mint Tower Capital Management’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,333	Closed	-$10K	–	408
2022 Q4	$10K	Buy	+33,333	New	+$6.71K	﹤0.01%	315

Mint Tower Capital Management's EBACW Position: Q1 2023 in Review

Mint Tower Capital Management sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 33,333 shares — an estimated $10K sold.

Mint Tower Capital Management first reported a position in EBACW in Q4 2022 and held it in 1 quarter. The position peaked at $10K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Mint Tower Capital Management reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Mint Tower Capital Management sold 33,333 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $10K.
Mint Tower Capital Management first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2022 and held it in 1 quarter.
Mint Tower Capital Management's European Biotech Acquisition Corp. Warrant position peaked at $10K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.